Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Barber, Neil
ACCTUATE, NCT05848037: Assessment of CymActive™ Catheter Technology for UrinAry ReTention and AcceptancE (The Study)	Recruiting	N/A	60	Europe	cymactive™ catheter device (CCD), Foley-type catheter device	Ingenion Medical Limited, Ingenion Medical Limited	Urinary Retention	12/25	12/25
CLEAR, NCT04338776: Comparing UroLift Experience Against Rezūm	Active, not recruiting	N/A	120	Europe, US	UroLift, Rezum	NeoTract, Inc.	Benign Prostatic Hyperplasia	05/25	12/25
NCT04757116: Post-Market Study to Assess iTind Safety in Comparison to UroLift	Recruiting	N/A	206	Europe, US	iTind, UroLift	Olympus Corporation of the Americas	Benign Prostatic Hyperplasia (BPH)	12/25	12/30
AUR87A, NCT04006405: AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC	Active, not recruiting	N/A	280	Europe, Canada, US	GAG score	Elypta	Clear Cell Renal Cell Carcinoma	05/25	12/25
NCT04658056: UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue	Not yet recruiting	N/A	46	Europe		PROCEPT BioRobotics	Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms	01/22	02/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Barber, Neil
ACCTUATE, NCT05848037: Assessment of CymActive™ Catheter Technology for UrinAry ReTention and AcceptancE (The Study)	Recruiting	N/A	60	Europe	cymactive™ catheter device (CCD), Foley-type catheter device	Ingenion Medical Limited, Ingenion Medical Limited	Urinary Retention	12/25	12/25
CLEAR, NCT04338776: Comparing UroLift Experience Against Rezūm	Active, not recruiting	N/A	120	Europe, US	UroLift, Rezum	NeoTract, Inc.	Benign Prostatic Hyperplasia	05/25	12/25
NCT04757116: Post-Market Study to Assess iTind Safety in Comparison to UroLift	Recruiting	N/A	206	Europe, US	iTind, UroLift	Olympus Corporation of the Americas	Benign Prostatic Hyperplasia (BPH)	12/25	12/30
AUR87A, NCT04006405: AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC	Active, not recruiting	N/A	280	Europe, Canada, US	GAG score	Elypta	Clear Cell Renal Cell Carcinoma	05/25	12/25
NCT04658056: UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue	Not yet recruiting	N/A	46	Europe		PROCEPT BioRobotics	Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms	01/22	02/22